Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry Campbell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerDébora B Vendramini-Costa, Ralph Francescone, Janusz Franco-Barraza, et al.
Gastroenterology|February 10, 2023
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator PhenotypeRossella Tricarico, Jozef Madzo, Gabrielle Scher, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerDébora B Vendramini-Costa, Ralph Francescone, Janusz Franco-Barraza, et al.
Gastroenterology|February 10, 2023
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator PhenotypeRossella Tricarico, Jozef Madzo, Gabrielle Scher, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 2